113 related articles for article (PubMed ID: 34155039)
1. Cardiac Tissue Factor Regulates Inflammation, Hypertrophy, and Heart Failure in Mouse Model of Type 1 Diabetes.
Cibi DM; Sandireddy R; Bogireddi H; Tee N; Ghani SABA; Singh BK; Mackman N; Singh MK; Singh A
Diabetes; 2021 Sep; 70(9):2131-2146. PubMed ID: 34155039
[TBL] [Abstract][Full Text] [Related]
2. TAX1BP1 downregulation by STAT3 in cardiac fibroblasts contributes to diabetes-induced heart failure with preserved ejection fraction.
Zuo GF; Wang LG; Huang L; Ren YF; Ge Z; Hu ZY; Zhang JJ; Chen SL
Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166979. PubMed ID: 38065272
[TBL] [Abstract][Full Text] [Related]
3. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
Paulus WJ; Tschöpe C
J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
[TBL] [Abstract][Full Text] [Related]
4. Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection Fraction.
Yap J; Tay WT; Teng TK; Anand I; Richards AM; Ling LH; MacDonald MR; Chandramouli C; Tromp J; Siswanto BB; ; Zile M; McMurray J; Lam CSP
J Am Heart Assoc; 2019 Sep; 8(17):e013114. PubMed ID: 31431116
[TBL] [Abstract][Full Text] [Related]
5. Role of Toll-like receptors and interferon regulatory factors in different experimental heart failure models of diverse etiology: IRF7 as novel cardiovascular stress-inducible factor.
Becher PM; Hinrichs S; Fluschnik N; Hennigs JK; Klingel K; Blankenberg S; Westermann D; Lindner D
PLoS One; 2018; 13(3):e0193844. PubMed ID: 29538462
[TBL] [Abstract][Full Text] [Related]
6. Augmented cardiac formation of oxidatively-induced carbonylated proteins accompanies the increased functional severity of post-myocardial infarction heart failure in the setting of type 1 diabetes mellitus.
Dennis KE; Hill S; Rose KL; Sampson UK; Hill MF
Cardiovasc Pathol; 2013; 22(6):473-80. PubMed ID: 23566587
[TBL] [Abstract][Full Text] [Related]
7. Type 1 diabetes mellitus abrogates compensatory augmentation of myocardial neuregulin-1β/ErbB in response to myocardial infarction resulting in worsening heart failure.
Odiete O; Konik EA; Sawyer DB; Hill MF
Cardiovasc Diabetol; 2013 Mar; 12():52. PubMed ID: 23530877
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Dipeptidyl Peptidase-4 Impairs Ventricular Function and Promotes Cardiac Fibrosis in High Fat-Fed Diabetic Mice.
Mulvihill EE; Varin EM; Ussher JR; Campbell JE; Bang KW; Abdullah T; Baggio LL; Drucker DJ
Diabetes; 2016 Mar; 65(3):742-54. PubMed ID: 26672095
[TBL] [Abstract][Full Text] [Related]
9. Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation.
Ter Maaten JM; Damman K; Verhaar MC; Paulus WJ; Duncker DJ; Cheng C; van Heerebeek L; Hillege HL; Lam CS; Navis G; Voors AA
Eur J Heart Fail; 2016 Jun; 18(6):588-98. PubMed ID: 26861140
[TBL] [Abstract][Full Text] [Related]
10. The disruption of invariant natural killer T cells exacerbates cardiac hypertrophy and failure caused by pressure overload in mice.
Takahashi M; Kinugawa S; Takada S; Kakutani N; Furihata T; Sobirin MA; Fukushima A; Obata Y; Saito A; Ishimori N; Iwabuchi K; Tsutsui H
Exp Physiol; 2020 Mar; 105(3):489-501. PubMed ID: 31957919
[TBL] [Abstract][Full Text] [Related]
11. Follistatin like 1 Regulates Hypertrophy in Heart Failure with Preserved Ejection Fraction.
Tanaka K; Valero-Muñoz M; Wilson RM; Essick EE; Fowler CT; Nakamura K; van den Hoff M; Ouchi N; Sam F
JACC Basic Transl Sci; 2016 Jun; 1(4):207-221. PubMed ID: 27430031
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of anticoagulant proteins, protein S and tissue factor pathway inhibitor, in the mouse myocardium with cardio-specific TNF-α overexpression.
Higuchi Y; Kubota T; Koyanagi M; Maeda T; Feldman AM; Makino N
Am J Physiol Heart Circ Physiol; 2012 Jun; 302(11):H2352-62. PubMed ID: 22492716
[TBL] [Abstract][Full Text] [Related]
13. Divergent tumor necrosis factor receptor-related remodeling responses in heart failure: role of nuclear factor-kappaB and inflammatory activation.
Hamid T; Gu Y; Ortines RV; Bhattacharya C; Wang G; Xuan YT; Prabhu SD
Circulation; 2009 Mar; 119(10):1386-97. PubMed ID: 19255345
[TBL] [Abstract][Full Text] [Related]
14. Myocardial reverse remodeling: how far can we rewind?
Rodrigues PG; Leite-Moreira AF; Falcão-Pires I
Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1402-22. PubMed ID: 26993225
[TBL] [Abstract][Full Text] [Related]
15. The G protein Gα11 is essential for hypertrophic signalling in diabetic myocardium.
Reuter H; Seuthe K; Korkmaz Y; Grönke S; Hoyer DP; Rottlaender D; Zobel C; Addicks K; Hoyer J; Grimminger P; Brabender J; Wilkie TM; Erdmann E
Int J Cardiol; 2013 Aug; 167(4):1476-85. PubMed ID: 22560942
[TBL] [Abstract][Full Text] [Related]
16. Reduced expression of adherens and gap junction proteins can have a fundamental role in the development of heart failure following cardiac hypertrophy in rats.
dos Santos DO; Blefari V; Prado FP; Silva CA; Fazan R; Salgado HC; Ramos SG; Prado CM
Exp Mol Pathol; 2016 Feb; 100(1):167-76. PubMed ID: 26708424
[TBL] [Abstract][Full Text] [Related]
17. Valsartan independent of AT₁ receptor inhibits tissue factor, TLR-2 and -4 expression by regulation of Egr-1 through activation of AMPK in diabetic conditions.
Ha YM; Park EJ; Kang YJ; Park SW; Kim HJ; Chang KC
J Cell Mol Med; 2014 Oct; 18(10):2031-43. PubMed ID: 25109475
[TBL] [Abstract][Full Text] [Related]
18. 3,3-Dimethyl-1-butanol attenuates cardiac remodeling in pressure-overload-induced heart failure mice.
Wang G; Kong B; Shuai W; Fu H; Jiang X; Huang H
J Nutr Biochem; 2020 Apr; 78():108341. PubMed ID: 32004931
[TBL] [Abstract][Full Text] [Related]
19. O-GlcNAcylation of Histone Deacetylase 4 Protects the Diabetic Heart From Failure.
Kronlage M; Dewenter M; Grosso J; Fleming T; Oehl U; Lehmann LH; Falcão-Pires I; Leite-Moreira AF; Volk N; Gröne HJ; Müller OJ; Sickmann A; Katus HA; Backs J
Circulation; 2019 Aug; 140(7):580-594. PubMed ID: 31195810
[TBL] [Abstract][Full Text] [Related]
20. Vascular miR-181b controls tissue factor-dependent thrombogenicity and inflammation in type 2 diabetes.
Witkowski M; Witkowski M; Saffarzadeh M; Friebel J; Tabaraie T; Ta Bao L; Chakraborty A; Dörner A; Stratmann B; Tschoepe D; Winter SJ; Krueger A; Ruf W; Landmesser U; Rauch U
Cardiovasc Diabetol; 2020 Feb; 19(1):20. PubMed ID: 32066445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
